Related references
Note: Only part of the references are listed.Engineered protein cages for selective heparin encapsulation
Salla Valimaki et al.
JOURNAL OF MATERIALS CHEMISTRY B (2021)
Recent advances in supramolecular antidotes
Hang Yin et al.
THERANOSTICS (2021)
Anticoagulation in hemodialysis: A narrative review
Sophie E. Claudel et al.
SEMINARS IN DIALYSIS (2021)
Water-Soluble 3D Covalent Organic Framework that Displays an Enhanced Enrichment Effect of Photosensitizers and Catalysts for the Reduction of Protons to H2
Zhong-Zheng Gao et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Heparin reversal by an oligoethylene glycol functionalized guanidinocalixarene
Qiaoxian Huang et al.
CHEMICAL SCIENCE (2020)
Dendrigraft of Poly-L-lysine as a Promising Candidate To Reverse Heparin-based Anticoagulants in Clinical Settings
Benjamin Ourri et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Unchain My Blood: Lessons Learned from Self-Assembled Dendrimers as Nanoscale Heparin Binders
Domenico Marson et al.
BIOMOLECULES (2019)
Lost in (Clinical) Translation: Recent Advances in Heparin Neutralization and Monitoring
Benjamin Ourri et al.
ACS CHEMICAL BIOLOGY (2019)
Amphiphilic multi-charged cyclodextrins and vitamin K co-assembly as a synergistic coagulant
Pei-yu Li et al.
CHEMICAL COMMUNICATIONS (2019)
In Situ Loading and Delivery of Short Single- and Double-Stranded DNA by Supramolecular Organic Frameworks
Bo Yang et al.
CCS CHEMISTRY (2019)
Approaches to prevent bleeding associated with anticoagulants: current status and recent developments
Manu Thomas Kalathottukaren et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Inactivated antithombin as anticoagulant reversal in a rat model of cardiopulmonary bypass: a potent and potentially safer alternative to protamine
Elsa P. Bianchini et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors
Manu T. Kalathottukaren et al.
BLOOD ADVANCES (2018)
Supramolecular organic frameworks (SOFs): homogeneous regular 2D and 3D pores in water
Jia Tian et al.
NATIONAL SCIENCE REVIEW (2017)
Effect of PEG-PDMAEMA Block Copolymer Architecture on Polyelectrolyte Complex Formation with Heparin
Salla Valimaki et al.
BIOMACROMOLECULES (2016)
Reversible hemostatic properties of sulfabetaine/quaternary ammonium modified hyperbranched polyglycerol
Jiying Wen et al.
BIOMATERIALS (2016)
The toxicology of heparin reversal with protamine: past, present and future
Emilia Sokolowska et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin
Jack E. Ansell et al.
THROMBOSIS RESEARCH (2016)
Nano-antidotes for drug overdose and poisoning
Vincent Forster et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The Hydrophobic Effect Revisited-Studies with Supramolecular Complexes Imply High-Energy Water as a Noncovalent Driving Force
Frank Biedermann et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Affinity-based design of a synthetic universal reversal agent for heparin anticoagulants
Rajesh A. Shenoi et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Three-dimensional periodic supramolecular organic framework ion sponge in water and microcrystals
Jia Tian et al.
NATURE COMMUNICATIONS (2014)
Anti-protamine-heparin antibodies: incidence, clinical relevance, and pathogenesis
Tamam Bakchoul et al.
BLOOD (2013)
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass
Grace M. Lee et al.
BLOOD (2013)
Heparin sensing and binding - taking supramolecular chemistry towards clinical applications
Stephen M. Bromfield et al.
CHEMICAL SOCIETY REVIEWS (2013)
Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery
Jiangbing Zhou et al.
NATURE MATERIALS (2012)
Principles and Practice of Thromboelastography in Clinical Coagulation Management and Transfusion Practice
Daniel Bolliger et al.
TRANSFUSION MEDICINE REVIEWS (2012)
Self-Assembling Ligands for Multivalent Nanoscale Heparin Binding
Ana C. Rodrigo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Protamine reversal of low molecular weight heparin: clinically effective?
Joost J. van Veen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2011)
Emerging options in the treatment of deep vein thrombosis and pulmonary embolism
Benjamin Brenner et al.
BLOOD REVIEWS (2011)
Routine use of fondaparinux in acute coronary syndromes: A 2-year multicenter experience
Francois Schiele et al.
AMERICAN HEART JOURNAL (2010)
Review: Anticoagulation for haemodialysis
Michael Suranyi et al.
NEPHROLOGY (2010)
Toxicity of cucurbit[7]uril and cucurbit[8]uril: an exploratory in vitro and in vivo study
Vanya D. Uzunova et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2010)
Serious anaphylactic reactions due to protamine sulfate: A systematic literature review
Mads Nybo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents
Mark A. Crowther et al.
BLOOD (2008)
Heparin and low-molecular-weight heparin
Elaine Gray et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Prophylaxis for thromboembolism in hospitalized medical patients
Charles W. Francis
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Antithrombotic therapy in cardiac surgery
Andre Vincentelli et al.
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2006)
The design and evaluation of heparin-binding foldamers
S Choi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight heparin
MA Crowther et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
